BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28631187)

  • 1. Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.
    Shek FH; Luo R; Lam BYH; Sung WK; Lam TW; Luk JM; Leung MS; Chan KT; Wang HK; Chan CM; Poon RT; Lee NP
    Cell Oncol (Dordr); 2017 Oct; 40(5):443-456. PubMed ID: 28631187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.
    Ying HY; Gong CJ; Feng Y; Jing DD; Lu LG
    J Dig Dis; 2017 Jun; 18(6):349-358. PubMed ID: 28544403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF; Cheung TT; Yip CW; Ng LW; Fung SW; Lo CM; Fan ST; Cheung ST
    Oncotarget; 2016 Apr; 7(16):21644-57. PubMed ID: 26942873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
    Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
    Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
    Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
    Front Immunol; 2022; 13():923031. PubMed ID: 35924241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
    Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases.
    Zhu C; Han H; Li J; Xu L; Liu F; Wu K; Liu X
    Biomed Res Int; 2019; 2019():9321494. PubMed ID: 31240230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma.
    Man KF; Zhou L; Yu H; Lam KH; Cheng W; Yu J; Lee TK; Yun JP; Guan XY; Liu M; Ma S
    Nat Commun; 2023 Nov; 14(1):7863. PubMed ID: 38030644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
    Drakaki A; Hatziapostolou M; Polytarchou C; Vorvis C; Poultsides GA; Souglakos J; Georgoulias V; Iliopoulos D
    BMC Cancer; 2015 Jul; 15():542. PubMed ID: 26206264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics.
    Yang C; Guo L; Du J; Zhang Q; Zhang L
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
    Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
    Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.
    Chen L; Li M; Li Q; Wang CJ; Xie SQ
    Mol Cancer; 2013 Dec; 12():157. PubMed ID: 24325363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.
    Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW
    Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
    Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
    Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDH17 is a downstream effector of HOXA13 in modulating the Wnt/β-catenin signaling pathway in gastric cancer.
    Qu LP; Zhong YM; Zheng Z; Zhao RX
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1234-1241. PubMed ID: 28387908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.